Uridine prevents tamoxifen-induced liver lipid droplet accumulation (Q33781931)

29 July 2017

title

Uridine prevents tamoxifen-induced liver lipid droplet accumulation (English)

1 reference

29 July 2017

1 reference

Thuc T Le

1

1 reference

29 July 2017

Yasuyo Urasaki

series ordinal

2

1 reference

29 July 2017

Giuseppe Pizzorno

series ordinal

3

1 reference

29 July 2017

publication date

23 May 2014

1 reference

BMC pharmacology & toxicology

29 July 2017

published in

1 reference

29 July 2017

volume

15

1 reference

29 July 2017

page(s)

27

1 reference

describes a project that uses

29 July 2017

ImageJ

1 reference

11 June 2022

https://www.ebi.ac.uk/europepmc/webservices/rest/PMC4064512/fullTextXML

inferred from PubMed Central ID database lookup

cites work

Disruption of uridine homeostasis links liver pyrimidine metabolism to lipid accumulation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4064512

Label-free evaluation of hepatic microvesicular steatosis with multimodal coherent anti-Stokes Raman scattering microscopy

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4064512

Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4064512

Imaging immune and metabolic cells of visceral adipose tissues with multimodal nonlinear optical microscopy

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4064512

Measuring energy metabolism in cultured cells, including human pluripotent stem cells and differentiated cells.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4064512

Differential Expression of Uridine Phosphorylase in Tumors Contributes to an Improved Fluoropyrimidine Therapeutic Activity

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4064512

SIRT3 deficiency and mitochondrial protein hyperacetylation accelerate the development of the metabolic syndrome

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4064512

Human fatty liver disease: old questions and new insights

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4064512

Fatty liver is associated with reduced SIRT3 activity and mitochondrial protein hyperacetylation

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4064512

Shedding new light on lipid biology with coherent anti-Stokes Raman scattering microscopy

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4064512

Coherent anti-stokes Raman scattering microscopy: chemical imaging for biology and medicine

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4064512

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4064512

Abnormalities in uridine homeostatic regulation and pyrimidine nucleotide metabolism as a consequence of the deletion of the uridine phosphorylase gene

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4064512

Incidence and risk factors for non-alcoholic steatohepatitis: prospective study of 5408 women enrolled in Italian tamoxifen chemoprevention trial

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4064512

Homeostatic control of uridine and the role of uridine phosphorylase: a biological and clinical update

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4064512

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4064512

Tamoxifen-induced fatty liver in patients with breast cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4064512

Tamoxifen inhibits nitrobenzylthioinosine-sensitive equilibrative uridine transport in human MCF-7 breast cancer cells

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4064512

Uracil metabolism--UMP synthesis from orotic acid or uridine and conversion of uracil to beta-alanine: enzymes and cDNAs.

28 July 2018

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4064512

28 July 2018

https://api.crossref.org/works/10.1186/2050-6511-15-27

Eukaryotic phospholipid biosynthesis

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4064512

Novel single-pass exchange of circulating uridine in rat liver

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4064512

Long-Term Benefits of 5 Years of Tamoxifen: 10-Year Follow-Up of a Large Randomized Trial in Women at Least 50 Years of Age With Early Breast Cancer

28 July 2018

1 reference

https://api.crossref.org/works/10.1186/2050-6511-15-27

Effects of tamoxifen on hepatic fat content and the development of hepatic steatosis in patients with breast cancer: high frequency of involvement and rapid reversal after completion of tamoxifen therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/2050-6511-15-27

Mechanisms of the deleterious effects of tamoxifen on mitochondrial respiration rate and phosphorylation efficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/2050-6511-15-27

Transcript and metabolite analysis of the effects of tamoxifen in rat liver reveals inhibition of fatty acid synthesis in the presence of hepatic steatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/2050-6511-15-27

Causes and prevention of tamoxifen-induced accumulation of triacylglycerol in rat liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/2050-6511-15-27

Uridine prevents fenofibrate-induced fatty liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/2050-6511-15-27

Uridine and its nucleotides: biological actions, therapeutic potentials

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/2050-6511-15-27

Chemical contrast for imaging living systems: molecular vibrations drive CARS microscopy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/2050-6511-15-27

Hepatic steatosis in liver transplant donors: common feature of donor population?

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/2050-6511-15-27

Assessment of hepatic steatosis by expert pathologists: the end of a gold standard

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/2050-6511-15-27

Uridine supplementation antagonizes zalcitabine-induced microvesicular steatohepatitis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/2050-6511-15-27

Relationships between tamoxifen use, liver fat and body fat distribution in women with breast cancer

21 January 2018

1 reference

12 December 2020

Metabolites, pharmacodynamics, and pharmacokinetics of tamoxifen in rats and mice compared to the breast cancer patient

1 reference

12 December 2020

Frozen section evaluation of donor livers before transplantation

1 reference

12 December 2020

Phase I clinical and pharmacological studies of benzylacyclouridine, a uridine phosphorylase inhibitor

1 reference

12 December 2020

Tamoxifen inhibits topoisomerases, depletes mitochondrial DNA, and triggers steatosis in mouse liver

1 reference

12 December 2020

Identifiers

DOI

10.1186/2050-6511-15-27

1 reference

29 July 2017

1 reference

29 July 2017

1 reference